UK Government puts forward revised biopharma R&D tax credit cap

The UK BioIndustry Association has welcomed revised proposals to ensure genuine biotech companies are not penalised by a cap on R&D tax credits

picture of

Breaking News

Croda working with partners on development of COVID-19 vaccination

During the emergence of the pandemic, Croda has actively reached out to research groups around the world, offering free ...

Tiziana develops novel treatment for COVID-19 patients using anti-interleukin-6-receptor mAbs

Company has filed patent application in support of treatment of COVID-19 utilizing anti-il6r via inhaled delivery

Five ways R&D contributes to the growth of the pharmaceutical industry

When it comes to research and development, the pharmaceutical industry has always been a massive player — now so more ...

New technology in cell and gene therapies to meet patient needs

Angela Myers, Head of Gene Editing and Novel Modalities at Merck, outlines the challenges arising with the increasing ...

GSK invests $250m in coronavirus R&D agreement

GSK has made an equity investment in Vir Biotechnology to gain access to its proprietary monoclonal antibody platform ...

Butterworth supports pharmaceutical industry during COVID-19 crisis

Butterworth Laboratories contract analytical laboratory remains open for business as (almost) usual

Sustainability and innovation in the complex combination therapy sector

The patient and commercial benefits of bringing new drugs to market in the shortest possible time are well recognised; ...

Laurus Labs partners to explore COVID-19 prophylaxis for health workers

US Rising Pharmaceuticals and Indian Laurus Labs have joined forces to explore hydroxychloroquine as preventive ...

Servier acquires therapeutic antibody discovery specialist Symphogen

Servier has agreed to gain full ownership of Symphogen’s proprietary pipeline of oncology and immuno-oncology ...

Cloud-based laboratory management solutions for increased productivity

Laboratory researchers across the globe are all challenged with similar barriers to productivity. Regardless of the ...

How AI will disrupt drug development

In the last 4–6 years, companies have been experimenting with new approaches that utilise the latest in artificial ...

Automation in the lab boosts real-time collaboration

The trend towards global collaboration in the lab is showing no sign of slowing, so companies must streamline this ...

Transatlantic partnership to screen 15,000 drugs for COVID-19 treatments

Exscientia has announced a joint initiative to identify COVID-19 drugs with Diamond Light Source and Scripps ...

Data standards: the key to making the "lab of the future" dream a reality

The lack of industry wide data standards could hold back innovation in life sciences R&D, suggest Dr Jarek Tomczak and ...